We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$6.86B
AUM Growth
-$3.41B
Cap. Flow
-$3.78B
Cap. Flow %
-55.19%
Top 10 Hldgs %
25.96%
Holding
2,871
New
973
Increased
552
Reduced
524
Closed
811

Top Buys

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$48M
2
AEP icon
American Electric Power
AEP
+$40.9M
3
CMCSA icon
Comcast
CMCSA
+$38.2M
4
ETR icon
Entergy
ETR
+$30.6M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$27.9M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$378M
2
AMZN icon
Amazon
AMZN
+$336M
3
AAPL icon
Apple
AAPL
+$294M
4
BABA icon
Alibaba
BABA
+$258M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$136M

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Consumer Discretionary 8.02%
3 Utilities 7.46%
4 Healthcare 7.42%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
Z icon
2001
Zillow
Z
$8.33B
$81K ﹤0.01%
624
-8,180
-93% -$1.21M
SYRS
2002
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$81K ﹤0.01%
1,078
-911
-46% -$94.6K
CBAY
2003
DELISTED
Cymabay Therapeutics
CBAY
$81K ﹤0.01%
+17,739
New +$95.5K
LBRDA
2004
DELISTED
Liberty Broadband Class A
LBRDA
$80K ﹤0.01%
551
-1,557
-74% -$231K
CRBP icon
2005
Corbus Pharmaceuticals
CRBP
$207M
$75K ﹤0.01%
+1,267
New +$83.3K
PRQR icon
2006
ProQR Therapeutics
PRQR
$343M
$71K ﹤0.01%
10,700
-20,402
-66% -$104K
ATNX
2007
DELISTED
Athenex, Inc. Common Stock
ATNX
$71K ﹤0.01%
+820
New +$157K
ARCO icon
2008
Arcos Dorados Holdings
ARCO
$1.7B
$70K ﹤0.01%
13,972
-662
-5% -$3.39K
ASMB icon
2009
Assembly Biosciences
ASMB
$718M
$69K ﹤0.01%
1,246
+175
+16% +$11.6K
MBII
2010
DELISTED
Marrone Bio Innovations, Inc.
MBII
$69K ﹤0.01%
+32,834
New +$68.2K
EZPW icon
2011
Ezcorp Inc
EZPW
$2.15B
$65K ﹤0.01%
+13,116
New +$65.9K
XLF icon
2012
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$65K ﹤0.01%
1,900
-663,455
-100% -$21.3M
VBIV
2013
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$65K ﹤0.01%
+698
New +$70.8K
APRE icon
2014
Aprea Therapeutics
APRE
$10.1M
$63K ﹤0.01%
+616
New +$71.9K
KPRX icon
2015
Kiora Pharmaceuticals
KPRX
$12.2M
$62K ﹤0.01%
+35
New +$76.3K
CALA
2016
DELISTED
Calithera Biosciences, Inc
CALA
$59K ﹤0.01%
+1,210
New +$70.4K
APTX
2017
DELISTED
Aptinyx Inc. Common Stock
APTX
$58K ﹤0.01%
+19,397
New +$69.7K
VVR icon
2018
Invesco Senior Income Trust
VVR
$451M
$55K ﹤0.01%
+13,054
New +$54.2K
ALNA
2019
DELISTED
Allena Pharmaceuticals
ALNA
$55K ﹤0.01%
+39,713
New +$66.2K
RNWK
2020
DELISTED
RealNetworks Inc
RNWK
$55K ﹤0.01%
+12,900
New +$45K
YPF icon
2021
YPF Sociedad Anonima ADS
YPF
$20.1B
$54K ﹤0.01%
+13,100
New +$55.4K
SD icon
2022
SandRidge Energy
SD
$519M
$53K ﹤0.01%
+13,665
New +$62.2K
XPRO icon
2023
Expro Ltd
XPRO
$2.01B
$53K ﹤0.01%
+2,483
New +$54K
KUST
2024
Kustom Entertainment Inc
KUST
$6.09M
– –
0
– –
CBIO
2025
Crescent Biopharma
CBIO
$630M
$52K ﹤0.01%
171
-380
-69% -$136K
79 80
81
82 83

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q1 2021 Portfolio in Review

As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.

  • Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
  • Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
  • Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
  • Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
  • Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
  • Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
  • Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.